Early-stage considerations for accelerating cell and gene therapy commercialization
On demand

Early-stage considerations for accelerating cell and gene therapy commercialization

Tuesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Early-stage considerations for accelerating cell and gene therapy commercialization

Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.

The cell and gene therapy field continues to advance at an unprecedented pace. In keeping up with the complex process development landscape and changing regulatory requirements, emerging biotechs and early-stage organizations ― including academia and research institutions ― face unique challenges.

From process development to scale-up considerations, this webinar will provide the essential knowledge and practical insights needed to accelerate the development of safe and effective cell and gene therapies, whilst reducing costs, and mitigating risk. It will include a case study on TIL process development, illustrating how it’s never too early to start thinking about commercialization.

  • Explore critical considerations in process development
  • Outline strategies for scale-up and quality control
  • Learn how to successfully translate to commercial-scale manufacturing
Sabrina Carmichael
Sabrina Carmichael
Fast Trak Global Technical Leader, Cytiva

Sabrina Carmichael is the Fast Trak Global Technical Leader at Cytiva. Fast Trak focuses on process development, training, and applications content development. In her role, Sabrina creates content for training courses and delivers those courses to customers interested in cell therapy manufacturing. She also engages with customers for process development, working with them to optimize and automate their cell therapy manufacturing processes. Prior to her work at Cytiva Sabrina was a Lab Manager and Lead Research Technologist at the Center for Platelet Research Studies at Boston Children's Hospital. At Boston Children's she worked on clinical trials related to pediatric and adult patients with various platelet disorders, focusing on flow cytometric analysis. Sabrina has also worked for The State of Massachusetts Department of Public Health as a Bacteriologist in an HIV and Hepatitis Diagnostics lab, as well as a Molecular Technologist for Genzyme Genetics focusing on prenatal diagnostics. Sabrina has a background in Biology and Biotechnology with a Master of Science degree in Biotechnology from Johns Hopkins University.